[1]
|
Derakhshan, F. and Reis-Filho, J.S. (2022) Pathogenesis of Triple-Negative Breast Cancer. Annual Review of Pathology: Mechanisms of Disease, 17, 181-204. https://doi.org/10.1146/annurev-pathol-042420-093238
|
[2]
|
Wang, X., Col-let, L., Rediti, M., Debien, V., De Caluwé, A., Venet, D., Romano, E., Rothé, F., Sotiriou, C. and Buisseret, L. (2023) Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges. Journal of Clinical Medicine, 12, Article 953. https://doi.org/10.3390/jcm12030953
|
[3]
|
Hua, Z., Li, D., Xiang, G., Xu, F., Jie, G., Fu, Z., Jie, Z., Da, P. and Li, D. (2011) PD-1 Polymorphisms Are Associated with Sporadic Breast Can-cer in Chinese Han Population of Northeast China. Breast Cancer Research and Treatment, 129, 195-201. https://doi.org/10.1007/s10549-011-1440-3
|
[4]
|
Boguszewska-Byczkiewicz, K., Wow, T., Szymańska, B., et al. (2023) The PD-1 Single-Nucleotide Polymorphism rs11568821 and rs2227981 as a Novel Prognosis Model in a Tri-ple-Negative Breast Cancer Patient. Molecular Biology Reports, 50, 6279-6285. https://doi.org/10.1007/s11033-023-08423-3
|
[5]
|
Zins, K., Peka, E., Miedl, H., Ecker, S., Abraham, D. and Schreiber, M. (2023) Association of the Telomerase Reverse Transcriptase rs10069690 Polymorphism with the Risk, Age at Onset and Prognosis of Triple Negative Breast Cancer. International Journal of Molecular Sciences, 24, Article 1825. https://doi.org/10.3390/ijms24031825
|
[6]
|
Wang, Y., Luo, W. and Wang, Y. (2019) PARP-1 and Its Asso-ciated Nucleases in DNA Damage Response. DNA Repair, 81, Article ID: 102651. https://doi.org/10.1016/j.dnarep.2019.102651
|
[7]
|
Green, A.R., et al. (2015) Biological and Clinical Significance of PARP1 Protein Expression in Breast Cancer. Breast Cancer Research and Treatment, 149, 353-362. https://doi.org/10.1007/s10549-014-3230-1
|
[8]
|
Zhai, L., et al. (2015) The Nuclear Expression of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Invasive Primary Breast Tumors Is Associated with Chemotherapy Sensitivity. Pathology, Research and Practice, 211, 130-137.
https://doi.org/10.1016/j.prp.2014.11.004
|
[9]
|
Liao, Y., Liao, Y., Li, J., Xiong, J. and Fan, Y. (2020) Polymor-phisms in PARP1 Predict Disease-Free Survival of Triple-Negative Breast Cancer Patients Treated with Anthracy-cline/Taxane Based Adjuvant Chemotherapy. Scientific Reports, 10, Article No. 7349. https://doi.org/10.1038/s41598-020-64473-8
|
[10]
|
Kleivi Sahlberg, K., Bottai, G., Naume, B., Burwinkel, B., Calin, G.A., Børresen-Dale, A.L. and Santarpia, L. (2015) A Serum microRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients. Clinical Cancer Research, 21, 1207-1214. https://doi.org/10.1158/1078-0432.CCR-14-2011
|
[11]
|
Goodall, G.J. and Wickramasinghe, V.O. (2021) RNA in Cancer. Nature Reviews Cancer, 21, 22-36.
https://doi.org/10.1038/s41568-020-00306-0
|
[12]
|
Fu, Y., Yang, Q., Yang, H. and Zhang, X. (2023) New Progress in the Role of microRNAs in the Diagnosis and Prognosis of Triple Negative Breast Cancer. Frontiers in Molecular Bi-osciences, 10, Article 1162463.
https://doi.org/10.3389/fmolb.2023.1162463
|
[13]
|
Lü, L., Mao, X., Shi, P., He, B., Xu, K., Zhang, S. and Wang, J. (2017) MicroRNAs in the Prognosis of Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis. Medi-cine, 96, e7085.
https://doi.org/10.1097/MD.0000000000007085
|
[14]
|
Fang, H., Xie, J., Zhang, M., Zhao, Z., Wan, Y. and Yao, Y. (2017) miRNA-21 Promotes Proliferation and Invasion of Triple-Negative Breast Cancer Cells through Targeting PTEN. American Journal of Translational Research, 9, 953-961.
|
[15]
|
Chen, J., Shin, V.Y., Siu, M.T., Ho, J.C., Cheuk, I. and Kwong, A. (2016) miR-199a-5p Confers Tumor-Suppressive Role in Triple-Negative Breast Cancer. BMC Cancer, 16, Article No. 887. https://doi.org/10.1186/s12885-016-2916-7
|
[16]
|
Xing, C., Sun, S.G., Yue, Z.Q. and Bai, F. (2021) Role of lncRNA LUCAT1 in Cancer. Biomedicine & Pharmacotherapy, 134, Article ID: 111158. https://doi.org/10.1016/j.biopha.2020.111158
|
[17]
|
Ciafrè, S.A., Russo, M., Michienzi, A. and Galardi, S. (2023) Long Noncoding RNAs and Cancer Stem Cells: Dangerous Liaisons Managing Cancer. International Journal of Molec-ular Sciences, 24, Article 1828.
https://doi.org/10.3390/ijms24031828
|
[18]
|
Kong, X., Liu, W. and Kong, Y. (2018) Roles and Expression Profiles of Long Non-Coding RNAs in Triple-Negative Breast Cancers. Journal of Cellular and Molecular Medicine, 22, 390-394. https://doi.org/10.1111/jcmm.13327
|
[19]
|
Wang, S., Ke, H., Zhang, H., Ma, Y., Ao, L., Zou, L., Yang, Q., Zhu, H., Nie, J., Wu, C. and Jiao, B. (2018) LncRNA MIR100HG Promotes Cell Proliferation in Triple-Negative Breast Cancer through Triplex Formation with p27 Loci. Cell Death & Disease, 9, Article No. 805. https://doi.org/10.1038/s41419-018-0869-2
|
[20]
|
Chen, F.Y., Zhou, Z.Y., Zhang, K.J., Pang, J. and Wang, S.M. (2020) Long Non-Coding RNA MIR100HG Promotes the Migration, Invasion and Proliferation of Triple-Negative Breast Cancer Cells by Targeting the miR-5590-3p/OTX1 Axis. Cancer Cell International, 20, Article No. 508. https://doi.org/10.1186/s12935-020-01580-6
|
[21]
|
Luo, L., Tang, H., Ling, L., Li, N., Jia, X., Zhang, Z., Wang, X., Shi, L., Yin, J., Qiu, N., Liu, H., Song, Y., Luo, K., Li, H., He, Z., Zheng, G. and Xie, X. (2018) LINC01638 lncRNA Activates MTDH-Twist1 Signaling by Preventing SPOP-Mediated c-Myc Degradation in Triple-Negative Breast Cancer. Oncogene, 37, 6166-6179.
https://doi.org/10.1038/s41388-018-0396-8
|
[22]
|
Niu, L., Fan, Q., Yan, M. and Wang, L. (2019) LncRNA NRON Down-Regulates lncRNA snaR and Inhibits Cancer Cell Proliferation in TNBC. Bioscience Reports, 39, BSR20190468. https://doi.org/10.1042/BSR20190468
|
[23]
|
Kumar, A. and Zhang, K.Y. (2015) Advances in the Development of SUMO Specific Protease (SENP) Inhibitors. Computational and Structural Biotechnology Journal, 13, 204-211. https://doi.org/10.1016/j.csbj.2015.03.001
|
[24]
|
Gao, Y., Wang, R., Liu, J., Zhao, K., Qian, X., He, X. and Liu, H. (2022) SENP1 Promotes Triple-Negative Breast Cancer Invasion and Metastasis via Enhancing CSN5 Transcription Mediated by GATA1 deSUMOylation. International Journal of Biological Sciences, 18, 2186-2201. https://doi.org/10.7150/ijbs.60594
|
[25]
|
Zhu, Y., Zhang, J., Yu, L., Xu, S., Chen, L., Wu, K., Kong, L., Lin, W., Xue, J., Wang, Q., Lin, Y. and Chen, X. (2023) SENP3 Promotes Tumor Progression and Is a Novel Prognostic Bi-omarker in Triple-Negative Breast Cancer. Frontiers in Oncology, 12, Article 972969. https://doi.org/10.3389/fonc.2022.972969
|
[26]
|
Bianchi, F., Pretto, S., Tagliabue, E., Balsari, A. and Sfondrini, L. (2017) Exploiting Poly(I:C) to Induce Cancer Cell Apoptosis. Cancer Biology & Therapy, 18, 747-756. https://doi.org/10.1080/15384047.2017.1373220
|
[27]
|
Su, R., Cai, L., Xiong, P., Liu, Z., Chen, S., Liu, X., Lin, R., Lei, Z., Tian, D. and Su, M. (2022) TLR3 Expression Is a Potential Prognosis Biomarker and Shapes the Immune-Active Tumor Microenvironment in Esophageal Squamous Cell Carcinoma. Journal of Inflammation Research, 15, 1437-1456. https://doi.org/10.2147/JIR.S348786
|
[28]
|
Le Naour, J., Galluzzi, L., Zitvogel, L., Kroemer, G. and Vacchelli, E. (2020) Trial Watch: TLR3 Agonists in Cancer Therapy. OncoImmunology, 9, Article ID: 1771143. https://doi.org/10.1080/2162402X.2020.1771143
|
[29]
|
Fan, L., Sui, X.Y., Jin, X., Zhang, W.J., Zhou, P. and Shao, Z.M. (2023) High Expression of TLR3 in Triple-Negative Breast Cancer Predicts Better Prognosis-Data from the Fudan University Shanghai Cancer Center Cohort and Tissue Microarrays. BMC Cancer, 23, Article No. 298. https://doi.org/10.1186/s12885-023-10721-9
|
[30]
|
Alcaraz, L.B., Mallavialle, A., Mollevi, C., Boissière-Michot, F., Mansouri, H., Simony-Lafontaine, J., Laurent-Matha, V., Chardès, T., Jacot, W., Turtoi, A., Roger, P., Guiu, S. and Liaudet-Coopman, E. (2023) SPARC in Cancer-Associated Fibroblasts Is an Independent Poor Prognostic Factor in Non-Metastatic Triple-Negative Breast Cancer and Exhibits Pro-Tumor Activity. International Journal of Cancer, 152, 1243-1258. https://doi.org/10.1002/ijc.34345
|
[31]
|
Alcaraz, L.B., Mallavialle, A., David, T., Derocq, D., Delolme, F., Dieryckx, C., Mollevi, C., Boissière-Michot, F., Simony-Lafontaine, J., Du Manoir, S., Huesgen, P.F., Overall, C.M., Tartare-Deckert, S., Jacot, W., Chardès, T., Guiu, S., Roger, P., Reinheckel, T., Moali, C. and Liaudet-Coopman, E. (2021) A 9-kDa Matricellular SPARC Fragment Released by Cathepsin D Exhibits Pro-Tumor Activity in the Tri-ple-Negative Breast Cancer Microenvironment. Theranostics, 11, 6173-6192. https://doi.org/10.7150/thno.58254
|
[32]
|
Bellenghi, M., Talarico, G., Botti, L., Puglisi, R., Tabolacci, C., Portararo, P., Piva, A., Pontecorvi, G., Carè, A., Colombo, M.P., Mattia, G. and Sangaletti, S. (2022) SCD5-Dependent Inhibition of SPARC Secretion Hampers Metastatic Spreading and Favors Host Immunity in a TNBC Murine Model. Oncogene, 41, 4055-4065.
https://doi.org/10.7150/thno.58254
|
[33]
|
Li, Z., Zhang, H., Wang, X., Wang, Q., Xue, J., Shi, Y., Wang, M., Wang, G. and Zhang, J. (2022) Identification of Cuproptosis-Related Subtypes, Characterization of Tumor Microenvironment Infiltration, and Development of a Prognosis Model in Breast Cancer. Frontiers in Immunology, 13, 996836. https://doi.org/10.3389/fimmu.2022.996836
|
[34]
|
Duan, F., Li, J., Huang, J., Hua, X., Song, C., Wang, L., Bi, X., Xia, W. and Yuan, Z. (2021) Establishment and Validation of Prognostic Nomograms Based on Serum Copper Level for Patients with Early-Stage Triple-Negative Breast Cancer. Frontiers in Cell and Developmental Biology, 9, Article 770115. https://doi.org/10.3389/fcell.2021.770115
|
[35]
|
Chen, L., Min, J. and Wang, F. (2022) Copper Homeostasis and Cuproptosis in Health and Disease. Signal Transduction and Targeted Therapy, 7, Article No. 378. https://doi.org/10.1038/s41392-022-01229-y
|
[36]
|
Sha, S., Si, L., Wu, X., Chen, Y., Xiong, H., Xu, Y., Liu, W., Mei, H., Wang, T. and Li, M. (2022) Prognostic Analysis of Cuproptosis-Related Gene in Triple-Negative Breast Cancer. Frontiers in Immunology, 13, Article 922780.
https://doi.org/10.3389/fimmu.2022.922780
|
[37]
|
Ajoolabady, A., Tang, D., Kroemer, G. and Ren, J. (2023) Fer-roptosis in Hepatocellular Carcinoma: Mechanisms and Targeted Therapy. British Journal of Cancer, 128, 190-205. https://doi.org/10.1038/s41416-022-01998-x
|
[38]
|
Xu, L., Liu, Y., Chen, X., Zhong, H. and Wang, Y. (2023) Fer-roptosis in Life: To Be or Not to Be. Biomedicine & Pharmacotherapy, 159, Article ID: 114241. https://doi.org/10.1016/j.biopha.2023.114241
|
[39]
|
Yuan, L., Liu, J., Bao, L., Qu, H., Xiang, J. and Sun, P. (2023) Upregulation of the Ferroptosis-Related STEAP3 Gene Is a Specific Predictor of Poor Triple-Negative Breast Cancer Pa-tient Outcomes. Frontiers in Oncology, 13, Article 1032364. https://doi.org/10.3389/fonc.2023.1032364
|